Tim Murawski, A Career on the Cutting Edge
Tim Murawski, President and Chief Commercial Officer of Augmedics, has put revolutionary technology in the hands of medical providers for thirty years. Whether working to get needleless IV products into the hands of healthcare providers during the 1990s HIV/AIDS crisis or growing the surgical robotics market in the 2000s, Mr. Murawski has worked to maximize clinical outcomes by giving physicians innovative tools. In his current role with Augmedics, Mr. Murawski leads a team that is introducing the revolutionary xvision Spine System (XVS) to surgeons across the United States.
The technology uses a headset and augmented reality to give an enhanced, 3-D view of a patient’s spinal anatomy during complex surgeries. The XVS received FDA approval in December 2019, just before the COVID-19 pandemic forced the shutdown of elective surgical procedures across the country (Topionetworks).
Despite the unprecedented challenge of marketing a new technology during a global pandemic, Mr. Murawski secured $15 million in Series B financing through investment by a combination of employees, existing stakeholders, and new investors. Augmedics was able to continue marketing the XVS through the pandemic and the device was used in over 250 spine procedures through the second half of 2020. Tim Murawski’s persistent vision and drive to maximize surgical outcomes for providers and patients has Augmedics positioned to make their revolutionary technology a standard tool for surgical procedures.
More information about Tim Murawski´s and Augmedics medical firm https://en.everybodywiki.com/Tim_Murawski